Search Results
Optimizing MM treatment through understanding resistance
Optimizing proteasome inhibitors for the treatment of multiple myeloma
Optimizing Therapy for High-Risk Newly Diagnosed MM
Optimizing the Use of Anti-BCMA Therapy in MM
Single-Cell Identification of SMM Clones Driving Myeloma Progression and Therapy Resistance
Optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
Optimising the management of multiple myeloma in the early relapsed/refractory setting
Multiple Myeloma: Optimizing Approaches to Transplant
Unravelling drug resistance and sensitization
Venetoclax Resistance: Mechanisms and Treatment Options
Irene Ghobrial | ESH MM 2018 | Optimizing liquid biopsies for use in MM
